Latest news with #EastmanChemical
Yahoo
07-07-2025
- Business
- Yahoo
Here's What to Expect From Eastman Chemical's Next Earnings Report
With a market cap of $9.2 billion, Eastman Chemical Company (EMN) is a global specialty materials manufacturer, with operations spanning the United States, China, and other international markets. The company produces a wide range of chemicals, plastics, and fibers that serve diverse industries, including transportation, construction, electronics, and healthcare. The Kingsport, Tennessee-based company is slated to announce its fiscal Q2 2025 earnings results after the market closes on Thursday, Jul. 31. Ahead of this event, analysts expect EMN to report an adjusted EPS of $1.77, a 17.7% decline from $2.15 in the year-ago quarter. However, it has exceeded Wall Street's earnings expectations in the past four quarters. Chevron Stock's 4.6% Dividend Yield and 1.67% One Month Short Put Yield Make CVX a Buy Tariff Dealine, Fed Minutes and Other Key Thing to Watch this Week SoFi Stock Is Betting on Crypto Again. How Should You Play SOFI Stock Here? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. For fiscal 2025, analysts forecast the specialty chemicals maker to report adjusted EPS of $7.22, marking a decrease of 8.5% from $7.89 in fiscal 2024. Nevertheless, adjusted EPS is anticipated to grow 12.6% year-over-year to $8.13 in fiscal 2026. Over the past 52 weeks, shares of Eastman Chemical have dropped 17%, underperforming the broader S&P 500 Index's ($SPX) 13.4% gain and the Materials Select Sector SPDR Fund's (XLB) 4.1% return over the same time frame. Despite Eastman Chemical reporting better-than-expected Q1 2025 adjusted EPS of $1.91 on Apr. 24, shares dipped 6.2% the next day as revenue came in at $2.3 billion, missing the consensus estimates. Segment-level underperformance, particularly in Advanced Materials and Fibers, which saw revenue declines of 3.9% and 12.9% respectively, signaled demand softness and pricing pressure. Moreover, Q2 guidance flagged ongoing headwinds from U.S.-China tariffs, elevated maintenance expenses, and only modest sequential volume growth, with the company projecting adjusted EPS in the range of $1.70 to $1.90. Analysts' consensus view on Eastman Chemical stock is cautiously optimistic, with a "Moderate Buy" rating overall. Among 15 analysts covering the stock, eight suggest a "Strong Buy," two give a "Moderate Buy," and five recommend a "Hold." As of writing, EMN is trading below the average analyst price target of $94.94. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Insider
05-07-2025
- Business
- Business Insider
Eastman Chemical (EMN) Gets a Buy from RBC Capital
RBC Capital analyst Arun Viswanathan maintained a Buy rating on Eastman Chemical on July 3 and set a price target of $91.00. The company's shares closed last Thursday at $79.57. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Viswanathan is an analyst with an average return of -3.3% and a 47.20% success rate. Viswanathan covers the Basic Materials sector, focusing on stocks such as PPG Industries, Sherwin-Williams Company, and Westlake Corporation. Eastman Chemical has an analyst consensus of Moderate Buy, with a price target consensus of $95.69.
Yahoo
01-07-2025
- Business
- Yahoo
Eastman Schedules Second-Quarter 2025 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast, and Release of Additional Information
KINGSPORT, Tenn., July 01, 2025--(BUSINESS WIRE)--Eastman Chemical Company (NYSE:EMN): Financial Results Release: Thursday, July 31, 2025 Approximately 4:15 p.m. Eastern Time Via wire distribution and News Center and SEC Form 8-K filing. Advance Slides, Webcast and Teleconference: Friday, August 1, 2025 8:00 a.m. Eastern Time Via listen-only live webcast and teleconference. Teleconference Pre-Registration: To speed up connecting into the teleconference, a pre-registration link for participants is available below. Upon registration, participants will receive unique dial-in information via email. Replay: A webcast replay, as well as a replay in downloadable MP3 format, will be available at Telephone replay available continuously beginning at approximately 1:00 p.m. Eastern Time, August 1, through 11:59 p.m. Eastern Time, August 11, 2025, Toll Free at +1 (866) 813-9403, passcode 957945. View source version on Contacts Investor Contact: Greg Riddle, 212-835-1620, griddle@ Media Contact: Tracy Kilgore Addington, 423-224-0498, tracy@
Yahoo
29-06-2025
- Business
- Yahoo
Eastman Chemical Company's (NYSE:EMN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
With its stock down 14% over the past three months, it is easy to disregard Eastman Chemical (NYSE:EMN). However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. In this article, we decided to focus on Eastman Chemical's ROE. ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In short, ROE shows the profit each dollar generates with respect to its shareholder investments. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The formula for ROE is: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Eastman Chemical is: 16% = US$926m ÷ US$5.9b (Based on the trailing twelve months to March 2025). The 'return' is the amount earned after tax over the last twelve months. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.16. See our latest analysis for Eastman Chemical So far, we've learned that ROE is a measure of a company's profitability. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features. To begin with, Eastman Chemical seems to have a respectable ROE. On comparing with the average industry ROE of 11% the company's ROE looks pretty remarkable. This probably laid the ground for Eastman Chemical's moderate 10% net income growth seen over the past five years. We then performed a comparison between Eastman Chemical's net income growth with the industry, which revealed that the company's growth is similar to the average industry growth of 9.7% in the same 5-year period. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. Doing so will help them establish if the stock's future looks promising or ominous. Has the market priced in the future outlook for EMN? You can find out in our latest intrinsic value infographic research report. With a three-year median payout ratio of 43% (implying that the company retains 57% of its profits), it seems that Eastman Chemical is reinvesting efficiently in a way that it sees respectable amount growth in its earnings and pays a dividend that's well covered. Besides, Eastman Chemical has been paying dividends for at least ten years or more. This shows that the company is committed to sharing profits with its shareholders. Our latest analyst data shows that the future payout ratio of the company over the next three years is expected to be approximately 40%. As a result, Eastman Chemical's ROE is not expected to change by much either, which we inferred from the analyst estimate of 15% for future ROE. On the whole, we feel that Eastman Chemical's performance has been quite good. Specifically, we like that the company is reinvesting a huge chunk of its profits at a high rate of return. This of course has caused the company to see substantial growth in its earnings. With that said, the latest industry analyst forecasts reveal that the company's earnings growth is expected to slow down. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29-06-2025
- Business
- Yahoo
Eastman Chemical Company's (NYSE:EMN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
With its stock down 14% over the past three months, it is easy to disregard Eastman Chemical (NYSE:EMN). However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. In this article, we decided to focus on Eastman Chemical's ROE. ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In short, ROE shows the profit each dollar generates with respect to its shareholder investments. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The formula for ROE is: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Eastman Chemical is: 16% = US$926m ÷ US$5.9b (Based on the trailing twelve months to March 2025). The 'return' is the amount earned after tax over the last twelve months. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.16. See our latest analysis for Eastman Chemical So far, we've learned that ROE is a measure of a company's profitability. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features. To begin with, Eastman Chemical seems to have a respectable ROE. On comparing with the average industry ROE of 11% the company's ROE looks pretty remarkable. This probably laid the ground for Eastman Chemical's moderate 10% net income growth seen over the past five years. We then performed a comparison between Eastman Chemical's net income growth with the industry, which revealed that the company's growth is similar to the average industry growth of 9.7% in the same 5-year period. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. Doing so will help them establish if the stock's future looks promising or ominous. Has the market priced in the future outlook for EMN? You can find out in our latest intrinsic value infographic research report. With a three-year median payout ratio of 43% (implying that the company retains 57% of its profits), it seems that Eastman Chemical is reinvesting efficiently in a way that it sees respectable amount growth in its earnings and pays a dividend that's well covered. Besides, Eastman Chemical has been paying dividends for at least ten years or more. This shows that the company is committed to sharing profits with its shareholders. Our latest analyst data shows that the future payout ratio of the company over the next three years is expected to be approximately 40%. As a result, Eastman Chemical's ROE is not expected to change by much either, which we inferred from the analyst estimate of 15% for future ROE. On the whole, we feel that Eastman Chemical's performance has been quite good. Specifically, we like that the company is reinvesting a huge chunk of its profits at a high rate of return. This of course has caused the company to see substantial growth in its earnings. With that said, the latest industry analyst forecasts reveal that the company's earnings growth is expected to slow down. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
